Allergy to class/drug
Cr >2x ULN or CrCl <40
Poor performance status
High risk myelodysplastic syndrome
Advanced malignancy
Thrombocytopenia <50,000
Hepatic impairment, Child-Pugh Class C
Caution if hepatic impairment, Child-Pugh Class A or B
Caution if renal impairment
Caution if concurrent nephrotoxic agent
Caution if hematologic disorder
Caution in patients >55yo
Deferasirox
Succimer
Deferoxamine
Colestipol
Ulipristal
EDTA
Dimercaprol
Senna